Location History:
- Molndal, SE (2014)
- Uppsala, SE (2015 - 2020)
Company Filing History:
Years Active: 2014-2020
Title: Innovations by Alex Karlsson-Parra: A Study of His Contributions to Immunology
Introduction
Alex Karlsson-Parra, a prominent inventor based in Uppsala, Sweden, has made significant contributions to the field of immunology through his innovative methods and patents. With a total of 9 patents to his name, his work is focused on advancing treatments for various viral infections and improving immunological responses.
Latest Patents
Among his latest patents is a groundbreaking method for the co-differentiation of monocytes from allogeneic donors. This patent discloses a method for producing non-exhausted immature dendritic cells (DCs) derived from two different allogeneic donors. The method involves providing a mixture of allogeneic leukocytes obtained from at least two different donors, isolating allogeneic monocytes from this mixture, and subsequently generating non-exhausted immature DCs from the isolated monocytes.
Another notable invention by Karlsson-Parra is a method for priming T cells, designed for in vitro applications. This method is suitable for administration to patients suffering from viral infections, with the invention also encompassing the composition obtained through the process and its various uses.
Career Highlights
Alex Karlsson-Parra is currently associated with Immunicum AB, where he continues to explore innovative solutions in immunotherapy. His expertise and research significantly contribute to the advancement of clinical methodologies that address critical health challenges.
Collaborations
Throughout his career, Karlsson-Parra has collaborated with esteemed colleagues, including Bengt Andersson and Anna-Carin Wallgren. These partnerships underline the importance of teamwork in the pursuit of innovation and scientific advancement.
Conclusion
With a strong portfolio of patents and ongoing contributions to immunology, Alex Karlsson-Parra stands out as a leading inventor in his field. His work not only showcases his inventive capabilities but also highlights the potential impact of his innovations on future therapeutic applications.